Ann Surg Oncol

1. SMITH HG, Henriksen TV, Andersen CL
   Potential of Circulating Tumor DNA in Stratifying Patients with Localized pMMR Colon Cancer to Neoadjuvant Therapy.
   Ann Surg Oncol. 2026 Apr 3. doi: 10.1245/s10434-026-19539.
   

   >> Share

   
   
2. GUPTA P, Godfrey EL, Schultz KS, Qiao L, et al
   ASO Author Reflections: New Insights for Personalized HIPEC Strategies in Colorectal Cancer Peritoneal Metastases.
   Ann Surg Oncol. 2026 Mar 28. doi: 10.1245/s10434-026-19312.
   

   >> Share

   
   

   
   Anticancer Res

3. KONDOR AE, Vereczkei A, Varga P, Sindler LD, et al
   The Role of MRI in the Preoperative Staging of Rectal Cancer: Ten-year Experience from a Single Tertiary Center.
   Anticancer Res. 2026;46:2125-2132.
   

   >> Share

   
   
4. SAELIM P, Ei ZZ, Racha S, Yokoya M, et al
   Methoxy and Ketone Substitutions of Resveratrol Enhance Its Anticancer Activity by Increasing MEK and ERK Binding Affinity in Colorectal Cancer Cells.
   Anticancer Res. 2026;46:1957-1966.
   

   >> Share

   
   
5. KATAYAMA R, Aoki T, Tashiro Y, Hirai T, et al
   Relationship Between Histopathological Growth Patterns and Indocyanine Green Fluorescence in Colorectal Liver Metastases.
   Anticancer Res. 2026;46:2087-2093.
   

   >> Share

   
   

   
   Br J Cancer

6. MCSORLEY ST, Burton P, Chantler D, Johnstone M, et al
   Faecal haemoglobin-based referral and investigation prioritisation is associated with colorectal cancer-specific survival in symptomatic patients: a retrospective observational study.
   Br J Cancer. 2026 Apr 2. doi: 10.1038/s41416-026-03378.
   

   >> Share

   
   
7. MARTIN J, Jones DA, Ellis L, Gray E, et al
   Modelled impact of a multi-cancer early detection screening programme on the demand for diagnostics in England.
   Br J Cancer. 2026;134:1190-1197.
   

   >> Share

   
   

   
   Br J Surg

8. CAVAZZONI E, Desantis M, Vivaldi C, Schafer H, et al
   Anal high-grade squamous intraepithelial lesions: identification, classification, and management.
   Br J Surg. 2026;113:znag006.
   

   >> Share

   
   

   
   Cancer Lett

9. GANJI SP, Behera SK, Reddy NR, Chowdary TVP, et al
   Quercetin targets cytochrome P450 enzyme (CYP1A2) in colorectal cancer.
   Cancer Lett. 2026 Mar 27:218455. doi: 10.1016/j.canlet.2026.218455.
   

   >> Share

   
   

   
   Clin Cancer Res

10. SHEN Y, Wei M, He Y, Yang T, et al
    Dynamic ctDNA Monitoring Guides Early Treatment Intensification in Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemotherapy.
    Clin Cancer Res. 2026;32:1293-1301.
    

    >> Share

    
    

    
    Clin Res Hepatol Gastroenterol

11. LI X, Chu T, Chen W, Zhang L, et al
    Predictive utility of the C-reactive protein-albumin-lymphocyte (CALLY) index in Colorectal cancer: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2026;50:102816.
    

    >> Share

    
    

    
    Dig Dis

12. GUNTUPALLI Y, Nimmagadda R, Potluri V, Majety SK, et al
    Blood-Based Circulating Tumor DNA for Early Detection of Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Dig Dis. 2026 Mar 30:1-27. doi: 10.1159/000551806.
    

    >> Share

    
    

    
    Dis Colon Rectum

13. YAMAMOTO T, Itatani Y, Aoyama R, Yoshida Y, et al
    Single Incision Plus One Robot-Assisted Surgery With Hugo RAS System for Right-Sided Colon Cancer.
    Dis Colon Rectum. 2026 Mar 27. doi: 10.1097/DCR.0000000000004160.
    

    >> Share

    
    

    
    Eur J Cancer

14. HOFHEINZ RD, Weikersthal LFV, Dechow T, Depenbusch R, et al
    Aflibercept and 5-FU vs. FOLFOX as 1st line treatment for older adults or frail elderly patients with metastatic colorectal cancer - The randomized phase 2 AIO / IKF ELDERLY trial (AIO-KRK-0117 / IKF 629).
    Eur J Cancer. 2026;239:116689.
    

    >> Share

    
    
15. WAGNER AD, Raeisi M, Rakez M, Diasio RD, et al
    Sex differences in efficacy and toxicity of first-line treatment of metastatic colorectal cancer: An analysis of 18,041 patients in the ARCAD CRC database.
    Eur J Cancer. 2026;238:116694.
    

    >> Share

    
    

    
    Eur J Surg Oncol

16. FITZSIMMONS TR, Bunjo Z, Neo EL, Badiei A, et al
    Metastatic response and short-term survival outcomes in patients with stage IV rectal cancer treated with curative intent in the era of Total Neoadjuvant Therapy.
    Eur J Surg Oncol. 2026;52:111464.
    

    >> Share

    
    
17. BUNJO Z, Seneviratne I, Murshed I, Bedrikovetski S, et al
    Statewide analysis of outcomes in patients with early-stage rectal cancer undergoing standard-of-care upfront resection.
    Eur J Surg Oncol. 2026;52:111484.
    

    >> Share

    
    
18. JACOBSEN S, Angenete E, Johnsson A, Lydrup ML, et al
    Long-term oncological outcomes after salvage surgery for anal squamous cell carcinoma - a national cohort study.
    Eur J Surg Oncol. 2026;52:111482.
    

    >> Share

    
    
19. PAU S, Eglinton T, Wang A, Fischer J, et al
    The role of artificial intelligence in pre-operative prediction of completeness of cytoreduction for peritoneal surface malignancies: a scoping review.
    Eur J Surg Oncol. 2026;52:111480.
    

    >> Share

    
    
20. LV Y, Wang F, Shen Y, Yin S, et al
    Redefining the role of carbon nanoparticles in colorectal cancer surgery: From lymph node yield to diagnostic paradox.
    Eur J Surg Oncol. 2026;52:111782.
    

    >> Share

    
    

    
    Gastroenterology

21. RAMAI D, Pan CW, Rodriguez B, Amdetsion G, et al
    Interventions for Increasing Colorectal Cancer Screening Uptake: A Systematic Review and Network Meta-Analysis.
    Gastroenterology. 2026 Apr 1:S0016-5085(26)00303.
    

    >> Share

    
    
22. WANG X, Du M, Hang D, Chan AT, et al
    Metabolomic pattern of ultra-processed food intake and risk of colorectal cancer precursors.
    Gastroenterology. 2026 Mar 30:S0016-5085(26)00265.
    

    >> Share

    
    

    
    Int J Cancer

23. ZOHAR K, Strecker M, Wartmann T, Shi W, et al
    Globo-H diagnostic stratification and identification of DUSP14 as a candidate target in colorectal cancer.
    Int J Cancer. 2026 Apr 1. doi: 10.1002/ijc.70461.
    

    >> Share

    
    
24. STANKIEWICZ KARITA HC, Magaret AS, Doody DR, Schouten JT, et al
    Nonavalent HPV vaccine to prevent recurrent anal or vulvar high-grade squamous intraepithelial lesions (VIVA trial): A randomized, double-blind, placebo-controlled trial.
    Int J Cancer. 2026 Feb 13. doi: 10.1002/ijc.70366.
    

    >> Share

    
    

    
    Int J Colorectal Dis

25. TAKEDA K, Yamada T, Ohta R, Uehara K, et al
    Analysis of diverting ileostomy for colorectal cancer surgery: stenosis and T4 invasion are risk factors of reoperation due to anastomotic leakage, even when ileostomy is performed.
    Int J Colorectal Dis. 2026;41:84.
    

    >> Share

    
    

    
    J Am Coll Surg

26. SOMMOVILLA J, Liska D
    Debate, Data, and Decision: A Patient-Centered Approach to Operation for Lynch-Associated Colon Cancer.
    J Am Coll Surg. 2026 Mar 27. doi: 10.1097/XCS.0000000000001946.
    

    >> Share

    
    

    
    J Surg Oncol

27. CHARALAMBIDI M, Hukkinen T, Kaprio T, Edin S, et al
    Demographic and Clinical Characteristics of Early-Onset Colorectal Cancer in Sweden and Finland: A Multicentre Retrospective Cohort Study Over Three Decades.
    J Surg Oncol. 2026 Apr 2. doi: 10.1002/jso.70246.
    

    >> Share

    
    

    
    Lancet

28. CERCEK A, Wilson C, Xu RH
    Announcing the Lancet Commission on colorectal cancer: addressing the rising global burden.
    Lancet. 2026 Mar 26:S0140-6736(26)00418-6. doi: 10.1016/S0140-6736(26)00418.
    

    >> Share

    
    

    
    Oncogene

29. ZHOU Z, La Ferlita A, Palavalli MH, Chen X, et al
    TWIST1 mediated transcriptional activation of SPON2 drives colorectal cancer peritoneal metastasis through stromal cell signaling network.
    Oncogene. 2026 Apr 3. doi: 10.1038/s41388-026-03743.
    

    >> Share

    
    
30. LI C, Liu Q, Shen H, Zou T, et al
    Fusobacterium nucleatum drives colorectal cancer progression through the circPTBP3/miR-760/PUM1 axis.
    Oncogene. 2026 Mar 31. doi: 10.1038/s41388-026-03746.
    

    >> Share

    
    
31. KUANG Z, Su Q, Liang W, Shen K, et al
    PRSS22 inhibits HMOX1-mediated ferroptosis and induces osteopontin cleavage to promote M2 macrophage polarization and colitis-associated carcinogenesis.
    Oncogene. 2026;45:1275-1286.
    

    >> Share

    
    

    
    Oncology (Williston Park)

32. YAN LEYFMAN MD
    When the World Stopped: A Lesson in Strength and Second Chances.
    Oncology (Williston Park). 2026;40:137.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

33. HARIPRAKASH JM, Zole E, Feng W, Hao D, et al
    Functional role of small extrachromosomal circular DNA in colorectal cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2523047123.
    

    >> Share

    
    

    
    World J Surg

34. PAN S, Wang G
    Perioperative Systemic Stress Phenotypes Predict Immune Recovery Failure, Molecular Residual Disease, and Long-Term Outcomes After Colorectal Cancer Surgery: A Prospective Cohort Study.
    World J Surg. 2026 Mar 31. doi: 10.1002/wjs.70360.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share